Cardio Diagnostics Holdings, Inc.
NASDAQ · us_market
No AI summary generated yet for this ticker.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
LOS ANGELES, CA - May 20, 2026 (NEWMEDIAWIRE) - Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company's mission to improve ...
AUSTIN, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advancemen
LOS ANGELES, CA - May 19, 2026 (NEWMEDIAWIRE) - Heart disease remains the leading cause of death worldwide, yet much of modern healthcare still focuses on reacting to cardiovascular events after they occur rather than identifying risk earlier and pre...
LOS ANGELES, CA - May 19, 2026 (NEWMEDIAWIRE) - Most people are aware that cardiovascular disease ("CVD") is the leading cause of death in the United States; what they might not know is that an estimated 80% of those cases are considered preventable ...
LOS ANGELES, CA - May 1, 2026 (NEWMEDIAWIRE) - Cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide, affecting millions of lives while driving substantial medical costs and resource de...
LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. Cardio ...
LOS ANGELES, CA - April 20, 2026 (NEWMEDIAWIRE) - Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease preventio...
AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via IBN -- Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy. Cardio Diagnostics develops and commercializes blood-based clin
LOS ANGELES, CA - April 1, 2026 (NEWMEDIAWIRE) - Cardio Diagnostics Holdings (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management...
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
CHICAGO, February 18, 2026--Cardio Diagnostics will host an investor conference call on Thursday, February 19, 2026, at 3 p.m. Central Time.
CHICAGO, November 05, 2025--Cardio Diagnostics will be presenting new data at the American Heart Association (AHA) Scientific Sessions.
KNOXVILLE, Tenn. & CHICAGO, October 28, 2025--Cardio Diagnostics today announced they are partnering with YMCA of East Tennessee to launch a customized program exclusively for its members.
CHICAGO, October 21, 2025--Cardio Diagnostics Holdings, Inc. today announced the Company has partnered with 15 new provider organizations across the United States.
Ekta Chopra, the chief digital information officer of e.l.f. Beauty, acts as a champion of generative AI and helps make it pervasive across the company with AI tools that can assist employees with research inquiries, IT requests, and data analytics.
Ekta Chopra, the chief digital information officer of e.l.f. Beauty, acts as a champion of generative AI and helps make it pervasive across the company with AI tools that can assist employees with research inquiries, IT requests, and data analytics.
NasdaqCM:CDIO 1 Year Share Price vs Fair Value Explore Cardio Diagnostics Holdings's Fair Values from the Community and...
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| DEShaw | quant | 74.8K | $1.12K | 0.00% | Unchanged | 2026-03-31 |